Mother-to-child HIV transmission and ARVs [1]

Science

Volumn 298, Issue 5601, 2002, Pages 2129-

  De Vlas, Sake J ^a   Nagelkerke, Nico J D ^a,b,c   Jha, Prabhat ^d   Plummer, Frank A ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MANITOBA   (Canada)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NEVIRAPINE;

HUMAN IMMUNODEFICIENCY VIRUS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG EFFICACY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LETTER; MATHEMATICAL MODEL; MOTHER CHILD RELATION; PRIORITY JOURNAL; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; CHILD; DEVELOPING COUNTRIES; DISEASE TRANSMISSION, VERTICAL; DRUG COSTS; DRUG RESISTANCE, VIRAL; FEMALE; HIV; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0037073943     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (12)

1. J. Stephenson, JAMA 277, 614 (1997).
2. L. A. Guay et al., Lancet 354, 795 (1999).
3. A. Telenti, G. Paolo Rizzardi, Rev. Med. Virol. 10,385 (2000).
4. W. H. Valenti AIDS Read. 12, 64 (2002).
5. P. Garcia de Olalla et al., J. Acquir. Immune Defic. Syndr 30,105 (2002).
6. M. W. 8orgdorff. K. Floyd, J. F. Broekmans, Bull World Health Org. 80, 217 (2002).
7. P. Farmer et al. Bull. World Health Org. 79,1145 (2001).
8. R. M. Grant et al., JAMA 288, 181 (2002).
9. See www.hivandhepatitis.com/recent/resistance/0708O2c.htmL
10. N. J. D. Nagelkerke et al., Bull. World Health Org. 80, 89(2002).
11. CIin. Infect. Dis. 33, ii (2001).
12. G. P. Gamett. L. Bartley, N. C. Grassly, R. H. Anderson, Nature Med. 8, 651 (2002).